Effect of 5-LOX/COX-2 common inhibitor DHDMBF30 on pancreatic cancer cell Capan2

Table 1 The inhibition of DHDMBF30 against the transplant human pancreatic tumor in the hairless mice

Groups	Tumor formation rate (%)	Tumor weight (g)
DHDMBF30 group	67 (4/6)	1.35 ± 0.47b
PBS group	100 (6/6)	2.92 ± 0.73

^bP < 0.01 vs PBS group.

Table 2 The effect of DHDMBF30 against VEGF proteins of the transplant pancreatic tumor

Groups	Absorbance	Expression area (&mgr;m2)
Experimental group	36.36 ± 7.23b	45.82 ± 9.67b
Control group	66.61 ± 9.63	73.06 ± 8.45

^bP < 0.01 vs control group.